Britta Lipinski | PhD Candidate – Antibody Discovery and Protein Engineering Merck KGaA
Merck Healthcare KGaA

Britta Lipinski is a PhD candidate in the Antibody Discovery and Protein Engineering Department of Merck KGaA, supervised by Stefan Zielonka, where she works in close collaboration with the group of Prof. Dr. Harald Kolmar at the Technical University of Darmstadt. Her research focuses on the development of bi- and multispecific antibodies for immunotherapy. She received her Master's degree in Biomolecular Engineering from the Technical University of Darmstadt in 2022, having previously completed her thesis at Merck KGaA on the engineering of single domain antibodies as NK cell engagers.